medicinal chemistry

154 projects

FP7Reintegration grant2010–2014Greece

COMPUT DRUG DESIGN · Targeting the mutated PI3Kα isoform for the development of novel anti-cancer agents

FP7Doctoral network2009–2013Netherlands

STARS · Scientific Training in Antimicrobial Research Strategies

7 partners · 5 countries

FP7Individual fellowship2009–2011Portugal

CYCLOTIDE MECHANISM · Elucidating the mechanism of action of cyclotides: ultra-stable proteins from plants

FP7Individual fellowship2009–2010Switzerland

STOADA · Synthesis of Targeted Organometallic Anticancer Drugs and their mode of Action

FP7Staff exchange2009–2013Portugal

PEP2BRAIN · Selected peptides as drug candidates directed to pain and neurodegeneration

5 partners · 3 countries

FP7Reintegration grant2009–2013Spain

AR BF3 BINDERS · Identification of the protein binders of the androgen receptor BF3 pocket, an allosteric modulator of AF2 coactivator recruitment

FP7Staff exchange2008–2012Greece

TOPCRYST · Novel tools for crystallisation of macromolecules

3 partners · 2 countries

FP6Individual fellowship2007–2008France

MTDI-DNA · Molecular Theory of Drug Intercalation into DNA

FP6Individual fellowship2007–2008United Kingdom

DRUG-DISCOVERY · Synthesis and screening of new small molecules with antibacterial activity: Discovery of novel biological targets

FP6Individual fellowship2006–2008Germany

PHYTOPHARM · Phytochemical and Pharmacological Study of Plants Used in Traditional Medicine in Cameroon

FP6Individual fellowship2006–2008Denmark

MODELING PH-DEPENCE · Modelling pH-Dependence in rational drug design

FP6Individual fellowship2006–2009United Kingdom

SPIROTENUIPESINES · Total Synthesis of the Potent Neurotrophic Factors Spirotenuipesine A and B

2 partners · 2 countries

FP6Individual fellowship2006–2008United Kingdom

P53MUT. REACTIVATORS · Computer-assisted drug discovery and biophysical characterisation of mutant re-activators of the transcription factor p53 as putative tumour therapeutics

FP6Reintegration grant2006–2008Lithuania

PLK1 INHIBITION · Inhibition of Cancer by Disrupting Interaction Between Polo-like Kinase 1 Polo-box Domain and Spindle Targets

FP6Doctoral network2006–2010France

BIOMEDCHEM · Training for new approaches in anti-parasite and anti-tumour drug discovery

FP6Individual fellowship2006–2010United Kingdom

MEDCHEM AT QUB/GSK · New methodologies to synthetise unnatural nucleosides, known and putative antiproliferative agents

FP6Individual fellowship2005–2007Germany

COMBINE-ENGINEER · A software tool for molecular design using protein structure-based quantitative structure activity relationships

FP6Other2005–2007Italy

PHARMAMAL · Investigation of the mechanism of action of antimalarial agents, by means of computational methods. Bases for the rational design of new antimalarial drugs

FP6Individual fellowship2005–2007United Kingdom

POLYKETOMACROCYCLES · Transannular Macrocyclisation and the concise total synthesis of Antifungal natural products

FP6Doctoral network2005–2009Italy

FOLDAMERS · Design, synthesis, Structural Characterization and biological evaluation of new peptidomimetics with a defined secondary structure

3 partners · 3 countries

FP6Staff exchange2004–2008Germany

SMARTSCREEN · Magnetic resonance in drug screening

4 partners · 4 countries

FP6Staff exchange2004–2008France

MET-CANCER THERAPY · Animal models and drug design for therapy of cancers induced by the oncogene, met

FP6Individual fellowship2004–2008Denmark

NAC-DRUG · Nucleic Acid Based Drug Design Training Center

FP6Individual fellowship2004–2006United Kingdom

MALKIN · Targetting malarial cell cycle kinases